Skip to content
Parakho

IOL Chemicals & Pharmaceuticals Ltd

NSE IOLCPBSE 524164iolcp.com

Q1 FY27, unaudited

Revenue
₹756.26 Cr
Profit after tax
₹64.40 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations756.26+37.08%2,319.06
Other income8.18+10.99%21.38
Total income764.44+36.74%2,340.44
Employee benefit expense71.21+23.52%248.26
Finance costs3.64−13.95%14.55
Depreciation & amortisation21.34+7.94%80.23
Total expenses677.75+31.97%2,144.87
Profit before tax86.69+90.49%184.36
Tax expense22.29+92.49%46.72
Profit after tax64.40+89.80%137.64
Total comprehensive income63.37+90.36%140.24
Earnings per share
Earnings per share, basic₹2.20₹4.69
Earnings per share, diluted₹2.20₹4.69

Q1 FY27 unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base unaudited, from the company’s filing with NSE. Source

FY26 unaudited, from the company’s filing with NSE. Source

Earnings call

Q4 FY26

IOL Chemicals and Pharmaceuticals reported its highest-ever quarterly revenue in Q4 FY26 at Rs 619 crore, up 17.4% year-on-year, with EBITDA growing nearly 40% to Rs 94 crore and margin improving to 15.2%. For the full year, revenue rose 11.5% to Rs 2,319 crore, EBITDA increased around 29% to Rs 290 crore, and profit after tax grew about 36% to Rs 138 crore. Management attributed the improvement to operational efficiencies, improved product mix, higher capacity utilisation across ibuprofen and non-ibuprofen APIs, and price increases in the chemical business.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 43 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 20 Aug 2026.